UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

Science translational medicine, 2019-08, Vol.11 (504)

2019

Volltextzugriff (PDF)

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

The Journal of clinical investigation, 2018-06, Vol.128 (6), p.2376-2388

2018

Volltextzugriff (PDF)

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4919-4928

2017

Volltextzugriff (PDF)

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Oncotarget, 2015-09, Vol.6 (28), p.26483-26493

2015

Volltextzugriff (PDF)

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Breast cancer research : BCR, 2017-11, Vol.19 (1), p.123-123, Article 123

2017

Volltextzugriff (PDF)

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3197-3204

2013

Volltextzugriff (PDF)

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Breast cancer research : BCR, 2017-12, Vol.19 (1), p.130-130, Article 130

2017

Volltextzugriff (PDF)

Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer

Breast cancer research : BCR, 2024-06, Vol.26 (1), p.1-11

2024

Volltextzugriff (PDF)

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

NPJ breast cancer, 2022-02, Vol.8 (1), p.16-16, Article 16

2022

Volltextzugriff (PDF)

Understanding American Indian Perceptions Toward Radiation Therapy

Cancer control, 2020-07, Vol.27 (3), p.1073274820945991

2020

Volltextzugriff (PDF)

Causes of death after breast cancer diagnosis: A US population‐based analysis

Cancer, 2020-04, Vol.126 (7), p.1559-1567

2020

Volltextzugriff (PDF)

Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

Annals of surgical oncology, 2018-05, Vol.25 (5), p.1350-1356

2018

Volltextzugriff (PDF)

Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads

Mayo Clinic proceedings, 2008-02, Vol.83 (2), p.197-203

2008

Volltextzugriff (PDF)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

NPJ breast cancer, 2022-12, Vol.8 (1), p.134-134, Article 134

2022

Volltextzugriff (PDF)

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

JAMA oncology, 2018-12, Vol.4 (12), p.1700

2018

Volltextzugriff (PDF)

Use of liposomal anthracyclines in Kaposi’s sarcoma

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 13), p.36-52

2004

Volltextzugriff (PDF)

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

NPJ breast cancer, 2023-01, Vol.9 (1), p.1-9, Article 1

2023

Volltextzugriff (PDF)

Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads

Mayo Clinic proceedings, 2008-02, Vol.83 (2), p.197-203

2008

Volltextzugriff (PDF)

The Future of Contrast-Enhanced Mammography

American journal of roentgenology (1976), 2018-02, Vol.210 (2), p.292-300

2018

Volltextzugriff (PDF)

Regional recurrence in the era of sentinel lymph node biopsy

The American journal of surgery, 2015-12, Vol.210 (6), p.1155-1161

2015

Volltextzugriff (PDF)

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.759-771

2021

Volltextzugriff (PDF)

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2017-06, Vol.35 (18), p.2028-2036

2017

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(204)

Publikationsform

Artikel
(233)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(126)
Humans
(113)
Oncology
(87)
Female
(81)
Adult
(67)
Middle Aged
(66)
Aged
(58)
Breast Cancer
(43)
Male
(40)
Chemotherapy
(37)
Breast Neoplasms - Drug Therapy
(36)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Breast Neoplasms - Pathology
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Treatment Outcome
(30)
Aged, 80 And Over
(26)
Tumors
(26)
Patients
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

Understanding American Indian Perceptions Toward Radiation Therapy

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Causes of death after breast cancer diagnosis: A US population‐based analysis

Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Use of liposomal anthracyclines in Kaposi’s sarcoma

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer

Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads

The Future of Contrast-Enhanced Mammography

Regional recurrence in the era of sentinel lymph node biopsy

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

Suchergebnisse filtern